Article
Medicine, Research & Experimental
Haoqi Zhao, Lan Wang, Shufang Wang, Xihua Chen, Min Liang, Xin Zhang, Jiedong Wang, Xiangbo Xu
Summary: The study revealed that the overexpression of CHN1 is associated with lymph node metastasis and low survival rates in cervical carcinoma patients. CHN1 overexpression promoted cell proliferation, migration, and invasion by inducing EMT-related transcription factors. Furthermore, in vitro experiments showed that CHN1 overexpression activated the Akt/GSK-3 beta/Snail signaling pathway.
JOURNAL OF TRANSLATIONAL MEDICINE
(2021)
Article
Cell Biology
Qing Song, Zhifen Han, Xinnan Wu, Yan Wang, Lihong Zhou, Liu Yang, Ningning Liu, Hua Sui, Jianfeng Cai, Qing Ji, Qi Li
Summary: In colorectal cancer (CRC), beta-arrestin1 promotes migration and metastasis of CRC cells by regulating the EMT process through the Wnt/β-catenin signaling pathways. This provides a novel therapeutic target for CRC metastasis.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Pharmacology & Pharmacy
Jialing Sun, Weicong Chen, Bin Wen, Mingjia Zhang, Haitao Sun, Xuemei Yang, Wenting Zhao, Lei La, Haiyan An, Jie Pang, Lei Gao, Songqi He
Summary: Biejiajian pill (BJJP) has been shown to be an effective therapeutic agent against hepatocellular carcinoma (HCC) through repression of the Akt/GSK-3 beta/Snail signaling cascade and epithelial-mesenchymal transition (EMT). In vitro and in vivo studies demonstrated that BJJP significantly inhibited the proliferation, metastasis, and infiltration of HCC cells, delayed HCC development and efficiently inhibited lung metastasis.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Hui Wang, Huichao Zhou, Hong Ni, Xiaohong Shen
Summary: COL11A1 promotes invasion and migration abilities of PDAC cells by activating the AKT/GSK-3 beta/Snail signaling pathway, inducing epithelial-mesenchymal transition (EMT) and cell stemness. Therefore, COL11A1 could serve as a potential therapeutic target for PDAC.
Article
Biochemistry & Molecular Biology
Shuchi Goyal, Manjinder Singh, Divya Thirumal, Pratibha Sharma, Somdutt Mujwar, Krishna Kumar Mishra, Thakur Gurjeet Singh, Ravinder Singh, Varinder Singh, Tanveer Singh, Sheikh F. Ahmad
Summary: Alzheimer's disease is caused by plaque agglomeration and entanglement in neural cells, leading to apoptosis. Current research is focused on GSK-3 inhibitor analogues for potential treatment advancements.
Article
Endocrinology & Metabolism
Shaohua Zeng, Zhenyu Feng, Jinpeng Gu, Hexin Xu, Jianwen Zeng, Tiejun Pan
Summary: This study found that Zey can inhibit the proliferation, migration, and invasion of prostate cancer cells. Its mechanism of action may be linked to the synergistic inhibition of the AKT/GSK-3 beta and Wnt5/GSK-3 beta signaling pathways, which further inhibits EMT in prostate cancer cells.
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
(2023)
Article
Oncology
Xinyu Li, Wen Chen, Chunkang Yang, Yisen Huang, Jing Jia, Rongyu Xu, Shen Guan, Ruijun Ma, Haitao Yang, Lifeng Xie
Summary: IGHG1 acts as an oncogene in gastric cancer by promoting cellular proliferation, migration, and chemo-resistance, and it activates the AKT/GSK-3/beta-Catenin axis to regulate these behaviors in gastric cancer cells.
CANCER CELL INTERNATIONAL
(2021)
Article
Multidisciplinary Sciences
Lynette Steele, Aarren J. Mannion, Gary Shaw, Kenneth A. Maclennan, Graham P. Cook, Christopher E. Rudd, Alison Taylor
Summary: GSK-3 plays a crucial role in T cell function and tumor immunity, with the isoforms GSK-3α and GSK-3β having differential effects on immune responses and tumor infiltration, working together to control PD-1 expression and tumor growth.
Article
Oncology
Liangyuan Chen, Qiumei Wu, Xunyu Xu, Caihong Yang, Jianbin You, Falin Chen, Yanfen Zeng
Summary: LDHC plays a crucial role in the progression of lung adenocarcinoma, with its high expression significantly correlated with aggressive tumor features and poor prognosis. Overexpression of LDHC induces lactate and ATP production in LUAD cells, enhances invasive and metastatic potential, and accelerates tumor growth.
EXPERIMENTAL CELL RESEARCH
(2021)
Article
Oncology
Hui Liu, Mangaladoss Fredimoses, Peijia Niu, Tingting Liu, Yan Qiao, Xueli Tian, Xiaobing Chen, Dong Joon Kim, Xiang Li, Kangdong Liu, Zigang Dong
Summary: EPRS is frequently overexpressed in GC tissues and its overexpression is associated with poor prognosis in GC patients. High expression of EPRS positively correlates with GC development both in vitro and in vivo by enhancing the WNT/GSK-3 beta/beta-catenin signaling pathway. XA and 4-HD can directly bind to EPRS to block this signaling pathway and inhibit gastric cancer growth.
Article
Biochemistry & Molecular Biology
Beatrice Balboni, Shailesh Kumar Tripathi, Marina Veronesi, Debora Russo, Ilaria Penna, Barbara Giabbai, Tiziano Bandiera, Paola Storici, Stefania Girotto, Andrea Cavalli
Summary: In this study, we identified promising GSK-3 beta inhibitors through 1D F-19 NMR fragment screening and biophysical assays. We also proposed an alternative screening workflow to overcome the limitations of common GSK-3 beta inhibitors and found selective inhibitors and/or inhibitors capable of modulating GSK-3 beta activity without complete inhibition.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Biochemistry & Molecular Biology
Stefania Demuro, Rita M. C. Di Martino, Jose A. Ortega, Andrea Cavalli
Summary: Protein kinases are crucial in CNS diseases, but the failure of clinical trials and drug development processes have posed challenges in treating neurological disorders. Recent drug design strategies have shown progress in developing disease-modifying agents for CNS diseases.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Cell & Tissue Engineering
Ning Wang, Qian Song, Hai Yu, Gang Bao
Summary: FBXO17 acts as a promotor of glioma development by modulating the Akt/GSK-3 beta/snail signaling pathway, leading to increased cell proliferation, migration, invasion, and EMT process.
CELL TRANSPLANTATION
(2021)
Article
Cell Biology
Lingjuan Wang, Sijin Ouyang, Bin Li, Hao Wu, Fengli Wang
Summary: Ferroptosis is a newly characterized form of non-apoptotic-programmed cell death that has implications in human diseases and potential therapeutic applications for cancer. GSK-3 beta acts as a positive modulator of ferroptosis by influencing cellular iron metabolism, indicating its potential as a target for cancer chemotherapy.
CELL DEATH DISCOVERY
(2021)
Article
Multidisciplinary Sciences
Samuel M. Law, Jie J. Zheng
Summary: Wnt signaling pathways play a significant role in various diseases. β-catenin is central to the canonical Wnt signaling pathway. CHIR-99021, a GSK-3β inhibitor, is widely used for studying this pathway. However, caution is needed when using CHIR-99021 at certain concentrations.